These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7998397)

  • 21. [The interferon system in viral hepatitis B].
    Parshina OV; Savitskiĭ GI; Nosik NN; Ketiladze ES; Ershov FI
    Vopr Virusol; 1988; 33(5):610-2. PubMed ID: 3146163
    [No Abstract]   [Full Text] [Related]  

  • 22. [The transformation of acute viral hepatitis B into chronic].
    Sorinson SN; Korochkina OV; Frolov AV; Shamshura OL; Fomin EA; Kuzovatova EE; Neumoina MV; Zhdanov IuE; Sivukhina NI
    Klin Med (Mosk); 1996; 74(2):37-40. PubMed ID: 8772101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Leukinferon in the treatment of severe forms of acute hepatitis B].
    Botsvadze ESh; Kuznetsov VP; Gogichaĭshvili ShSh
    Ter Arkh; 1989; 61(11):50-4. PubMed ID: 2633393
    [No Abstract]   [Full Text] [Related]  

  • 24. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-2 and natural killer activity in acute type B hepatitis.
    Echevarria S; Casafont F; Miera M; Lozano JL; de la Cruz F; San Miguel G; Pons Romero F
    Hepatogastroenterology; 1991 Aug; 38(4):307-10. PubMed ID: 1937376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An assessment of the therapeutic efficacy of gene-engineered human alpha 2-interferon in patients with acute viral hepatitis B].
    Pokrovskiĭ VI; Zmyzgova AV; Botsvadze ESh; Andreĭchin MA; Frolov VM; Murzabaeva RT; Mesniankin AP; Kokareva LN; Malinovskaia VV
    Ter Arkh; 1990; 62(2):139-43. PubMed ID: 2186494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer response to exogenous interferon in delta hepatitis: boost or depression defined within the first week of therapy.
    Actis GC; Maran E; Rosina F; Saracco G; Rocca G; Rizzetto M; Bonino F; Verme G
    Digestion; 1987; 37(1):51-8. PubMed ID: 3609505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The dynamic production of interferons, interleukins and arachidonic acid metabolites by the blood cells of children with glomerulonephritis associated with HB virus infection while treated with reaferon].
    Markarian AS; Malinovskaia VV; Dlin VV; Ignatov MS; Asratian AA; Pronin AV
    Vopr Virusol; 1993; 38(4):152-6. PubMed ID: 7694426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interferon preparations in the treatment of acute and chronic forms of hepatitis B].
    Botsvadze ESh; Katsitadze TK; Kuznetsov VP; Kvitashvili MA; Gogichaĭshvili ShSh
    Ter Arkh; 1988; 60(8):79-82. PubMed ID: 3067414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.
    Hunter CA; Timans J; Pisacane P; Menon S; Cai G; Walker W; Aste-Amezaga M; Chizzonite R; Bazan JF; Kastelein RA
    Eur J Immunol; 1997 Nov; 27(11):2787-92. PubMed ID: 9394800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reaferon and interferonogenes in the therapy of acute viral hepatitis B].
    Andreĭchin MA; Zmyzgova AV; Rudchik AS
    Klin Med (Mosk); 1991 Mar; 69(3):77-80. PubMed ID: 2067345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of leukinferon in treating measles in adult patients].
    Nikolaeva IN; Kuznetsov VP; Barer GM; Parkhomenko IuG; Beliaev DL; Sinitsyna OV; Babaiants AA; Iushchuk ND
    Stomatologiia (Mosk); 1995; 74(3):32-5. PubMed ID: 7570694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activation of the interferon system enzymes by recombinant alpha2-interferon in patients with chronic hepatitis B].
    Sokolova TM; Bugaeva NP; Suetina IA; Ershov FI; Ketiladze ES
    Antibiot Khimioter; 1989 Jun; 34(6):472-5. PubMed ID: 2552947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The modulation of the interferon system by gamma-globulin preparations].
    Grigorian SS; Semenenko TA; Katkov AI; Ershov FI
    Vopr Virusol; 1991; 36(1):53-5. PubMed ID: 1713374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. alpha-Interferon therapy in patients with chronic active hepatitis B: immunological profile.
    Raptopoulou-Gigi M; Orphanou-Koumerkeridou H; Lagra F; Vacolas J; Goulis G; Vrettou H
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):330-4. PubMed ID: 1669591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Change in interferon status in patients with acute viral hepatitis during intramuscular and rectal administration of genetically engineered alpha-2-interferon].
    Malinovskaia VV; Neumoina MV; Budanov SV
    Vopr Virusol; 1994; 39(6):269-72. PubMed ID: 7536374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of interferon inducers and reaferon in the combined therapy of acute viral hepatitis B].
    Andreĭchin MA; Rudchik AS; Borak VF
    Ter Arkh; 1988; 60(11):29-32. PubMed ID: 3238572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of amyxin--a domestic analog of tilorone--on characteristics of interferon and immune status of man].
    Sel'kova EP; Semenenko TA; Nosik NN; Iudina TI; Amarian MP; Lavrukhina LA; Pantiukhova TN; Tarasova GIu
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (4):31-5. PubMed ID: 11569258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha interferon plus thymopentine in treatment of HBV and/or HDV positive patients undergoing liver transplant.
    Gaeta A; Mancini C; Bachetoni A; Sallusto F; Lorino G; Marinucci G; Di Giacomo C; Favalli C; Alfani D; Filadoro F
    J Biol Regul Homeost Agents; 1990; 4(2):51-6. PubMed ID: 2260503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Change in the activity of natural killer cells in normal subjects and in virus diseases on exposure to interferon in vitro].
    Petrov RV; Saidov MZ; Koval'chuk LV; Sorokin AM; Kaganov BS
    Biull Eksp Biol Med; 1984 Apr; 97(4):438-40. PubMed ID: 6722306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.